Effect of isoproterenol on adenylate cyclase activity in adipocytes of spontaneously hypertensive rats

1980 ◽  
Vol 90 (2) ◽  
pp. 1082-1085
Author(s):  
M. B. Reznikova ◽  
Yu. V. Postnov
Keyword(s):  
Adenylate Cyclase ◽  
Spontaneously Hypertensive Rats ◽  
Cyclase Activity ◽  
Adenylate Cyclase Activity ◽  
Hypertensive Rats ◽  
Spontaneously Hypertensive

scholarly journals Enhanced myocardial adenylate cyclase activity in spontaneously hypertensive rats.

1992 ◽  
Vol 56 (3) ◽  
pp. 301-309 ◽  
Author(s):  
FUMITAKA OHSUZU ◽  
SHUUICHI KATSUSHIKA ◽  
SHIN-ICHI MAIE ◽  
MASAHIKO AKANUMA ◽  
SHIGEKI YANAGIDA ◽  
...  
Keyword(s):  
Adenylate Cyclase ◽  
Spontaneously Hypertensive Rats ◽  
Cyclase Activity ◽  
Adenylate Cyclase Activity ◽  
Hypertensive Rats ◽  
Spontaneously Hypertensive

scholarly journals Enhanced expression of inhibitory guanine nucleotide regulatory protein in spontaneously hypertensive rats. Relationship to adenylate cyclase inhibition

1992 ◽  
Vol 288 (1) ◽  
pp. 79-85 ◽  
Author(s):  
M B Anand-Srivastava
Keyword(s):  
Adenylate Cyclase ◽  
G Protein ◽  
G Proteins ◽  
Spontaneously Hypertensive Rats ◽  
Regulatory Protein ◽  
Cyclase Activity ◽  
Adenylate Cyclase Activity ◽  
Hypertensive Rats ◽  
Spontaneously Hypertensive ◽  
Heart Sarcolemma

We have previously shown that the stimulatory effects of guanine nucleotides, N-ethylcarboxamide-adenosine and other agonists on adenylate cyclase activity were diminished in aorta and heart sarcolemma of spontaneously hypertensive rats (SHR) [Anand-Srivastava (1988) Biochem. Pharmacol. 37, 3017-3022]. In the present studies, we have examined whether the decreased response of these agonists is due to the defective GTP-binding proteins (G-proteins) which couple the receptors to adenylate cyclase, and have therefore measured the levels of G-proteins in aorta and heart from SHR and their respective Wistar-Kyoto (WKY) controls by using pertussis toxin (PT)- and cholera toxin (CT)-catalysed ADP-ribosylations and immunoblotting techniques using specific antibodies against G-proteins. The labelling with [32P]NAD+ and PT identified a 40/41 kDa protein in heart and aorta from WKY and SHR and was significantly increased in the hearts (approximately 100%) and aorta (approximately 30-40%), from SHR as compared with WKY. Immunoblotting revealed an increase in the levels of the G-protein alpha-subunits Gi alpha-2 and Gi alpha-3 in heart and Gi alpha-2 in aorta, whereas no change in Go alpha was observed in heart from SHR and WKY. On the other hand, no differences were observed in CT labelling or immunoblotting of stimulatory G-protein (Gs) in heart and aorta from WKY and SHR. In addition, CT stimulated the adenylate cyclase activity in heart sarcolemma from WKY and SHR to a similar extent. These results were correlated with adenylate cyclase inhibition and stimulation by various hormones. Angiotensin II (AII), atrial natriuretic factor (ANF) and oxotremorine-mediated inhibition was found to be greater in SHR as compared with WKY, whereas the stimulatory effects of adrenaline, isoprenaline, dopamine and forskolin were diminished in SHR aorta as compared to WKY. These results indicate that regulatory protein G(i) is more expressed in SHR, which may be associated with the decreased responsiveness of stimulatory hormones and increased sensitivity of inhibitory hormones to stimulate/inhibit adenylate cyclase activity. It may thus be suggested that the enhanced G(i) activity may be one of the mechanisms responsible for the diminished vascular tone and impaired myocardial functions in hypertension.

Sign in / Sign up

Export Citation Format

Share Document